Zephyr Listed as a Prominent Vendor in the Global Sleep Apnea Diagnostic & Therapeutic Devices Market

Zephyr Listed as a Prominent Vendor in the Global Sleep Apnea Diagnostic & Therapeutic Devices Market

Lewes, DE — (ReleaseWire) — 03/12/2015 — Report forecast the Global Sleep Apnea Diagnostic and Therapeutic Devices market to grow at a CAGR of 8.16 percent over the period 2014-2019.

Sleep apnea is a common sleeping disorder that breaks breath many times during sleep. OSA is the common type of sleep apnea, and it causes snoring, when the soft tissue in the back of the throat relaxes during sleep and blocks the airway. Sleep apnea symptoms includes morning headaches, waking up frequently to urinate, and dry mouth and sore in the morning. Sleep apnea diagnostic devices such PSG, actigraphy systems, and pulse oximeters are used for the screening of sleep apnea, while positive airway pressure and oral appliances are used for sleep apnea therapy.

The report covers the present scenario and the growth prospects of the Global Sleep Apnea Diagnostic and Therapeutic Devices market for the period 2015-2019. The market can be segmented into two: Sleep Apnea Diagnostic Devices and Sleep Apnea Therapeutic Devices.

According to the lead analyst of this report,high adoption of home diagnostics for diagnosis of sleep apnea is a key trend ibn this market. Home diagnostics are convenient and cost-effective when compared to in-lab sleep tests and therefore are expected to propel the market growth.

According to the report, high prevalence of sleep apnea disorder in people worldwide is a major driver in the market. The disorder is common in both adults and children and can result in hypertension, stroke, type II diabetes or adult onset diabetes, weight gain, impotence and cardiovascular diseases.

Further, the report states that lack of patient compliance is a key challenges in the market. Discomfort coupled with nosebleeds, anxiety, appliance leaking, claustrophobia and nasal stuffiness contribute to non-compliance when using CPAP or BiPAP devices.

The Global Sleep Apnea Diagnostic and Therapeutic Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Sleep Apnea Diagnostic and Therapeutic Devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

This report covers the following companies as the key players in the Global Sleep Apnea Diagnostic and Therapeutic Devices Market: Fisher & Paykel Healthcare Ltd., Philips Healthcare and ResMed Inc.

Other Prominent Vendors in the market are: Apnex Medical, Briggs Healthcare, Bunnell, Cadwell Laboratories, Carefusion, Clement Clarke International, Cleveland Medical Devices, Compumedics, Dehaier Medical Systems, DeVilbiss Healthcare, Drager Medical, Embla Systems, GE Healthcare, Hamilton Medical, ImThera Medical, Invacare, Itamar Medical, Natus Medical, Nihon Kohden, Salter Labs, Teleflex Medical, Ventus Medical, Weinmann Geraete fuer Medizin and Zephyr Sleep Technologies.

SHARE YOUR CART
%d bloggers like this: